MANDOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mandol, and when can generic versions of Mandol launch?
Mandol is a drug marketed by Lilly and is included in two NDAs.
The generic ingredient in MANDOL is cefamandole nafate. There are five drug master file entries for this compound. Additional details are available on the cefamandole nafate profile page.
Summary for MANDOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 1,674 |
DailyMed Link: | MANDOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MANDOL
US Patents and Regulatory Information for MANDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-001 | Sep 10, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-002 | Sep 10, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |